摘要:
The present invention relates to a positive electrode which includes a composite material, containing sulfur and carbon, as an active material. The invention also relates to the method for manufacturing said electrode, to a lithium-sulfur battery including such a positive electrode, and to the method for manufacturing said battery.
摘要:
The present invention relates to a compound of formula (I) The invention further relates to a process for manufacturing the compound of formula (I) and to a process for manufacturing an halogenated or radio-halogenated compound using compound of formula (I). The invention also relates to a device for implementing the halogenating process of the invention and to a kit comprising the compound of formula (I).
摘要:
The invention relates to a microstructured substrate comprising a plurality of at least one elementary microstructure (3), and to the method for producing said microstructured substrate. Said at least one elementary microstructure (3) has a long shape and opposing longitudinal lower (3a) and upper (3b) ends, the lower end (3a) being connected to the substrate, and also comprises an open cavity (5) on the upper end (3b) thereof, said microstructured substrate comprising alumina on the surface thereof. The invention also relates to an electrical storage device, more specifically an all-solid battery, comprising the microstructured substrate according to the invention.
摘要:
The invention relates to a viscoelastic material characterised in that it is produced by recovery of the hydrophobic phase obtained by a method of hydrothermal liquefaction from a biomass comprising at least one microalga and comprising at least 40 wt.% of water in relation to the total weight of the biomass, said hydrophobic phase comprising a viscoelastic oil and solid residues, wherein the quantity of solid residues amounts to between 15 wt.% and 30 wt.% of the total weight of the hydrophobic phase.
摘要:
Dispositif séparateur d'embruns (1), qui comporte un cadre (2) et un premier et un second ensembles (E 1 ; E 2 ) de profilés longitudinaux et verticaux non jointifs (3 ; 5) de section droite concave, les extrémités haute et basse de ces profilés (3 ; 5) étant reliées audit cadre (2), ces profilés (3 ; 5) délimitant une face externe (FE) et une face interne (FI), la concavité des profilés (3) du premier ensemble (E 1 ) étant dirigée vers ladite face interne (FI) tandis que celle des profilés (3 ; 5) du second ensemble (E 2 ) dirigée vers ladite face externe (FE), les profilés (3 ; 5) des deux ensembles (E 1 ; E 2 ) étant disposés en quinconce, de sorte que les deux bords longitudinaux de chaque profilé (5) dudit deuxième ensemble (E 2 ) se situent respectivement en regard de deux profilés voisins (3) dudit premier ensemble (E 1 ). Ce dispositif se caractérise en ce qu'il comporte des moyens de réglage (6 ; 7) de l'écartement entre lesdits deux ensembles (E 1 ; E 2 ).
摘要:
The present invention describes a composition comprising a mixture of human foetal keratinocyte cells and human foetal fibroblast cells, the ratio between said keratinocyte and fibroblast cells ranging from 0.75 to 2.5, preferably being 1 :1 or 7 :3. This composition is advantageously included in a bandage, said bandage preferably being sterile and packaged in a container impermeable to microorganisms. The present invention finally concerns the use of this composition as a drug, in particular for treating a skin defect (wound, burn or ulcer).
摘要:
The present invention relates to a macroporous, resorbable and injectable apatitic calcium-phosphate cement with a high compressive strength useful as bone cement and releasing a bone resorption inhibitor, preparation method and uses thereof.
摘要:
The present invention relates to compound of formula (I), their method of preparation and use thereof in particular in the fields of optoelectronic, photonic, photovoltaics and biology.
摘要:
The invention concerns methods for predicting whether a cancer patient will respond to therapy, of monitoring efficiency of a treatment of cancer, for determining a therapeutic regimen suitable for treating a subject suffering from a cancer, said methods comprising determining the level of expression of at least one gene selected from a panel of markers in a biological sample from the patient. The present invention further concerns a kit comprising means for detecting said panel of markers.